SEC Form 4 · accession 0001209191-15-053264
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Jun 12, 2015
Accepted (ET)
Jun 15, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $26.01 | Jun 12, 2015 | A | 10,000 | A | Jun 12, 2016 | Jun 12, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option becomes exercisable in full on the first anniversary of the date of the initial annual grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the options become fully vested in the event of a change in control of the Company.